Concepedia

Rüdiger E. Port

RE

15

Publications

1.2K

Citations

13

H-Index

1983

Active since

Affiliations

German Cancer Research Center(Current)

Heidelberg University

DKFZ-ZMBH Alliance

Rüdiger E. Port is an author at German Cancer Research Center specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

MedicinePharmacologyOncologyPharmacotherapyHealthToxicologyCancer ResearchPharmacokineticsRadiation OncologyRadiology

Publications per year

1983–2004

15

Publications

15

Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR Imaging

Gunnar Brix, Wolfhard Semmler, Rüdiger E. Port et al. · Journal of Computer Assisted Tomography · 1991 · 660 citations

Dynamic Mr, Engineering, Medical Imaging +15

Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.

William E. Hull, Rüdiger E. Port, Richard Herrmann et al. · PubMed · 1988 · 131 citations

Engineering, Nmr Spectroscopy, Metabolomic Profiling +26

Quantitative aspects of chemical carcinogenesis and tumor promotion in liver.

Heinz W. Kunz, Henk Tennekes, Rüdiger E. Port et al. · Environmental Health Perspectives · 1983 · 73 citations · Full text

Pathology, Phenobarbital Treatment, Tumor Biology +19

A population model for the leukopenic effect of etoposide*

Mats O. Karlsson, Rüdiger E. Port, Mark J. Ratain et al. · Clinical Pharmacology & Therapeutics · 1995 · 69 citations

Inflammation, Therapeutic Drug Monitoring, Oncology +13

Relative Importance of Dose, Body Surface Area, Sex, and Age for 5-Fluorouracil Clearance

Rüdiger E. Port, Barbel Daniel, Reinhard W. Ding et al. · Oncology · 1991 · 66 citations

Mtx Pretreatment, Fu Clearance, Oncology +15

Rows per page

1–5 of 15